Sign inJoin waitlistJoin the waitlist

Praneeth Baratam

Assistant Professor, Hematology & Oncology · Medical University of South Carolina College of Medicine

Credentials: · · · · · · ·

History

Drexel University College of Medicine/Hahnemann University
2010–2013
Internal Medicine
Ascension Saint Joseph Hospital
2007–2010
Andhra Medical College
2003–2007

Research

Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors
Cancer · 2020 · 86 citations
Final phase 1 substudy results of ivosidenib for patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome
Blood Advances · 2024 · 47 citations
Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapy
Blood Advances · 2024 · 8 citations

Courtney DiNardo
2 papers
Georgio Medawar
2 papers · 2 as a fellow
Michael Styler
2 papers
Robert Stuart
2 papers
Abhishek Tripathi
1 paper
Alexander Coltoff
1 paper
Alexander Sankin
1 paper
Alexandra Drakaki
1 paper
Ali Khaki
1 paper · 1 as a fellow
Amir Fathi
1 paper
AO
Andie O'Laughlin
1 paper
Ang Li
1 paper

Clinical trials

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Site PI · Recruiting · Phase 3
Takeda
2026–2034
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2029
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2027
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2029